Boston Scientific Corp. Stock Rises Thursday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Boston Scientific Corp. (BSX) rose 1.11% to $48.07 Thursday, on what proved to be an all-ar
Boston Scientific Hit With $42M Verdict in Drug-eluting Stents IP Case
8 Analysts Have This to Say About Boston Scientific
Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter: BullishSomewhat BullishIndifferentSomewhat BearishBearishTotal Ratings52100Last 30D210001M Ago010002M A
Needham Raises Price Target on Boston Scientific to $53 From $48, Maintains Buy Rating
09:22 AM EST, 02/02/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
Boston Scientific Is Maintained at Overweight by JP Morgan
Boston Scientific Price Target Raised to $55.00/Share From $48.00 by JP Morgan
Analysts Have Conflicting Sentiments on These Healthcare Companies: Align Tech (ALGN), Boston Scientific (BSX) and Evelo Biosciences (EVLO)
Boston Scientific Price Target Raised to $56.00/Share From $54.00 by Raymond James
Boston Scientific Is Maintained at Strong Buy by Raymond James
Raymond James Reaffirms Their Buy Rating on Boston Scientific (BSX)
Loading...
No Stock Yet